Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes

Geeta Geeta Sharma1, Ines Mota2, Luca Mologni3,4

  • 1Department of Medicine and Surgery, University of Milano-Bicocca, Monza 20900, Italy. geeta.geeta@unimib.it.

Cancers
|March 3, 2018
PubMed

Insights

Anaplastic lymphoma kinase (ALK) inhibitors effectively treat ALK-rearranged cancers like non-small-cell lung cancer (NSCLC). However, drug resistance frequently emerges, necessitating new strategies to overcome treatment limitations.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Anaplastic lymphoma kinase (ALK) is a key target in ALK-rearranged cancers, notably non-small-cell lung cancer (NSCLC).
  • ALK tyrosine kinase inhibitors (TKIs) like crizotinib were developed to target these malignancies.
  • Acquired resistance to ALK TKIs is a significant clinical challenge, limiting long-term patient benefit.

Purpose of the Study:

  • To review the physiological role and oncogenic function of ALK.
  • To provide an update on ALK inhibitors, including second and third-generation agents.
  • To summarize resistance mechanisms and explore therapeutic strategies to overcome TKI resistance.

Main Methods:

  • Literature review of ALK function, inhibitors, and resistance mechanisms.
  • Analysis of clinical and preclinical data on ALK-targeted therapies.
  • Synthesis of information on emerging resistance pathways and novel therapeutic approaches.

Main Results:

  • ALK plays a critical role in normal development and cancer transformation.
  • Multiple generations of ALK TKIs have been developed, showing initial efficacy but eventual resistance.
  • Diverse resistance mechanisms, both intrinsic and acquired, have been identified.
  • Emerging resistance necessitates the development of next-generation inhibitors and combination strategies.

Conclusions:

  • Understanding ALK's role and resistance mechanisms is crucial for improving NSCLC treatment.
  • Novel therapeutic strategies are needed to overcome acquired resistance to ALK TKIs.
  • Continued research into ALK biology and drug development holds promise for better patient outcomes.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
6.1K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Equivalent Resistance01:16

Equivalent Resistance

In circuit analysis, situations often arise where resistors are neither in series nor parallel configurations. To tackle such scenarios, three-terminal equivalent networks like the wye (Y) (Figure 1 (a)) or tee (T) and delta (Δ) (Figure 1 (b)) or pi (π) networks come into play. These networks offer versatile solutions and are frequently encountered in various applications, including three-phase electrical systems, electrical filters, and matching networks.
1.0K
Resistance and Conductance01:25

Resistance and Conductance

A conductor's DC resistance at a given temperature is influenced by its resistivity, length, and cross-sectional area. Resistivity is an inherent property of the conductor material, with annealed copper serving as the international standard for measurement. For instance, the resistivity of hard-drawn aluminum at 20 degrees Celsius is 61% of the standard conductivity of annealed copper.
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
531